Alba - a Mobile App to Provide Bereavement Support for Adolescents in Grief
Condition(s) studied
Investigational drug(s) / intervention(s)
Alba - Youth in grief: The app will build on principles of cognitive behavioural theory and therapy (CBT) and contains five main sections: Learning, Self-assessment, Manage symptoms, Find support and a Personal space.
Control website: The website will contain information about grief and grief reactions similar to some of the information given in the app.
Study summary
The goal of this two-armed randomised controlled trial is to evaluate a psychosocial self-management mobile app providing bereavement support to adolescents in grief. The main questions it aims to answer are:
1. How do adolescents in grief interact with and use the app?
2. How do bereaved adolescents perceive the usability of the app?
3. Is the intervention feasible?
4. How is the meaningfulness of using the app perceived among adolescents in grief and what effect do the adolescents perceive it to have on their grieving process and everyday life?
5. Does access to the app affect symptoms of grief, complicated grief, post-traumatic stress and depression among bereaved adolescents?
Participants will:
* Test the app (intervention group) or a website containing (control group) psychoeducation for 2 months
* Fill out online questionnaires regarding their mental health (baseline, post, 6 months, 12 months).
* Fill out an online questionnaire regarding the acceptability and usability of the app (intervention group)
* Be asked to participate in narrative interviews (intervention group)
Researchers will compare the intervention group with the control group to see if the app has an effect on bereaved adolescents mental health.
Eligibility
Primary outcome measure(s)
- Change (from baseline) in Traumatic Grief Inventory-Kids-Self report — 2, 6 and 12 months
16-item, self-rated measure of complicated grief, total score ranges from 16 to 80, where higher score indicates more symptoms
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Uppsala university | Uppsala | Sweden |
More Uppsala University trials in Sweden
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06093113 on ClinicalTrials.gov ↗ ← All trials in Sweden